Aytu BioScience, Inc.(AYTU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AYTU Aytu BioScience, Inc.

Post-Mkt 10-29 18:54:35 EDT

1.98

+0.01

+0.51%

盘后1.98

+0.000.00%

16:10 EDT

High1.99	Low1.95	Vol9.46K
Open1.95	D1 Closing1.97	Amplitude2.03%
Mkt Cap21.52M	Tradable Cap17.59M	Total Shares10.87M
T/O18.68K	T/O Rate0.11%	Tradable Shares8.88M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AYTU","market":"US","secType":"STK","nameCN":"Aytu BioScience, Inc.","latestPrice":1.98,"timestamp":1793304000000,"preClose":1.97,"halted":0,"volume":9464,"hourTrading":{"tag":"盘后","latestPrice":1.98,"preClose":1.98,"latestTime":"16:10 EDT","volume":169,"amount":334.62,"timestamp":1793304604584,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0050761421319797,"floatShares":8882690,"shares":10866708,"eps":-1.16,"marketStatus":"Post-Mkt","change":0.01,"latestTime":"10-29 18:54:35 EDT","open":1.95,"high":1.99,"low":1.95,"amount":18677,"amplitude":0.020305,"askPrice":1.98,"askSize":1,"bidPrice":1.89,"bidSize":311,"shortable":3,"etf":0,"ttmEps":-1.16,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1793318400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.97,"postHourTrading":{"tag":"盘后","latestPrice":1.98,"preClose":1.98,"latestTime":"16:10 EDT","volume":169,"amount":334.62,"timestamp":1793304604584,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.395401,"impliedVol":2.5831,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/AYTU/tweets","defaultTab":"tweets","newsList":[{"id":"2669120332","title":"Aytu Biopharma Inc Reports Results for the Quarter Ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2669120332","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669120332?lang=en_us&edition=fundamental","pubTime":"2026-09-23 05:58","pubTimestamp":1790114328,"startTime":"0","endTime":"0","summary":"Aytu Biopharma Inc reports results for the quarter ended March 31 - Earnings SummaryAytu Biopharma IncAYTU.OQreported a quarterly adjusted loss of 53 cents per share for the quarter ended March 31, lo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL8N45E1T4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AYTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669412748","title":"Aytu Fiscal Q4 2026 Earnings: EXXUA Drives Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2669412748","media":"TradingKey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669412748?lang=en_us&edition=fundamental","pubTime":"2026-09-23 05:08","pubTimestamp":1790111297,"startTime":"0","endTime":"0","summary":"Aytu BioPharma’s fiscal Q4 2026 net revenue rose 6.4% to $16.1 million, while diluted net loss per share improved to $0.00 from $2.92 a year earlier. EXXUA generated $3.9 million in its first full launch quarter and helped offset declines in the ADHD and Pediatric portfolios. Gross margin narrowed to 64.6% from 67.8%, and adjusted EBITDA fell to $0.5 million from $2.0 million as commercialization spending increased. The company ended June 30, 2026 with $26.3 million in cash, down from $31.0 million a year earlier.","market":"other","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock1.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock1.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/earnings/262181336-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","AYTU","ABVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669577122","title":"Aytu BioPharma Q4 Revenue Beats Analyst Estimates on EXXUA Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2669577122","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669577122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:17","pubTimestamp":1790108275,"startTime":"0","endTime":"0","summary":"Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA salesOverviewUS pharmaceutical firm's fiscal Q4 revenue rose 6.4%, beating analyst expectationsCompany reported near break-even net loss for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL1N45E0WU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYTU","IE0009355771.USD","IE00B4R5TH58.HKD","LU0109394709.USD","BK4139","AMGN","IE00BFTCPJ56.SGD","PBE","SG9999001440.SGD","BK4585","BIB","LU0320765992.SGD","LU2112291526.USD","BK4534","BK4566","IE0002141913.USD","IBBQ","LU2089984988.USD","IBB","TBXU","BK4599","BK4533","LU0868494617.USD","LU1571399168.USD","BBH","LU1023059063.AUD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","PJP","BK4581","BK4007","IE00BJJMRZ35.SGD","LU1057294990.SGD","BK4588","LU0289739699.SGD","LU2468319806.SGD","LU1061106388.HKD","LU0122379950.USD","LU0058720904.USD","LU1983299246.USD","LU2242652126.USD","LU0889565916.HKD","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669122867","title":"Aytu BioPharma Q4 EPS $0.00 Beats $(0.33) Estimate, Sales $16.106M Beat $12.276M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122867","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122867?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:07","pubTimestamp":1790107661,"startTime":"0","endTime":"0","summary":"Aytu BioPharma Q4 EPS $0.00 Beats $(0.33) Estimate, Sales $16.106M Beat $12.276M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/AYTU","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Aytu BioPharma Q4 EPS $0.00 Beats $(0.33) Estimate, Sales $16.106M Beat $12.276M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYTU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669122893","title":"Aytu BioPharma Q4 EPS $0.00 and Sales $16.106M Beat $12.276M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122893","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122893?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:06","pubTimestamp":1790107613,"startTime":"0","endTime":"0","summary":"Aytu BioPharma (NASDAQ:AYTU) reported quarterly sales of $16.106 million which beat the analyst consensus estimate of $12.276 million by 31.20 percent.  This is a 6.42 percent increase over sales of $15.135 million the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61933898/aytu-biopharma-q4-eps-0-00-and-sales-16-106m-beat-12-276m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AYTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669859122","title":"Aytu BioPharma Q4 FY26 Net Loss Narrows to USD 15,000; Revenue Rises 6.4% to USD 16.1 Million vs Q4 FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2669859122","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669859122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:06","pubTimestamp":1790107561,"startTime":"0","endTime":"0","summary":"Aytu BioPharma Q4 FY26 net loss narrows to USD 15,000; revenue rises 6.4% to USD 16.1 million vs Q4 FY25Aytu Biopharma reported Q4 fiscal 2026 net revenue rose 6.4% to USD 16.1 million versus the year","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL2Pc3Z6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AYTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669240161","title":"Aytu Biopharma Q4 Gross Profit USD 10.409 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669240161","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669240161?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:05","pubTimestamp":1790107501,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nPLXL8BCCM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AYTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669124090","title":"Aytu Biopharma Q4 Net Income USD -15 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2669124090","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669124090?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:05","pubTimestamp":1790107501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nPLXL8BCCM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AYTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669122349","title":"Aytu Biopharma Q4 EPS USD 0","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122349","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122349?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:05","pubTimestamp":1790107501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nPLXL8BCCM:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AYTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669525341","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2669525341","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669525341?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:00","pubTimestamp":1789984800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·Thor Indus Inc.                                  4Q       .89   6:30 AM. ·General Mills Inc.                               1Q       .72   7:00 AM. ·Stitch Fix Inc. Cls A                           4Q      (.06)      AMC. ·TD SYNNEX Corp                                   3Q      4.68   7:00 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","LU0965509010.AUD","LU1989763690.USD","LU1037948541.HKD","BBUL","BK4137","LU2506951958.HKD","LU0980610538.SGD","LU0234570918.USD","BK4596","LU0265550946.USD","LU1989763427.SGD","LU0238689110.USD","LU2433249047.HKD","LU1620156213.USD","BK4581","DRI","LU0689472784.USD","BK4007","LU0154245673.USD","LU0314106906.USD","BK4006","IE00BVYPNV92.GBP","LU2168564149.EUR","LU0965509283.SGD","XHB","LU0417517546.SGD","LU0661504455.SGD","LU0823434740.USD","BB","COST","LU1201861249.SGD","BK4585","FUL","RSPS","BK4213","BK4155","IE00B5TLWC47.USD","BK4533","LU0345770993.USD","LU1620156130.USD","LU1032955483.USD","CBRL","LU0234572021.USD","LU0648001328.SGD","BK4097","LU1066053197.SGD","SFIX","LU1037948897.HKD","LU0823434583.USD","KBH","AYTU","LU1116320737.USD","LU1596574779.USD","BK4140","BK4094","DAVA","THO","LU1551013425.SGD","LU2506951875.HKD","LU0471298694.HKD","LU1196500208.SGD","LU0648005311.SGD","FSTA","XLP","IE00BDGV0183.EUR","SG9999001440.SGD","IE00BGHQF631.EUR","LU1923622614.USD","LU1571399168.USD","LU1496350171.SGD","LU2360032135.SGD","LU0943347566.SGD","RTH","HK0000819398.USD","LU0084288595.USD","BK4109","LU1506573853.SGD","BK4096","BK4214","COTG","LU2168563687.JPY","LU2381873111.SGD","LU0265550359.USD","LU2125909593.SGD","AZO","LU1721427968.SGD","LU1035775433.USD","BK4550","GIS","IE00B3T34201.USD","LU2168564222.USD","LU1221951046.USD","BK4504","TRUO","LU1066051811.HKD","LU0820561909.HKD","IE0008368304.USD","LU0963586101.USD","LU0823417737.USD","LU0950375773.USD","LU2413665964.HKD","BK4099","LU0965509101.SGD","LU1585245621.USD","BK4597","BK4588","LU0823417653.USD","BK4143","BK4551","LU1069344957.HKD","LU0965508806.USD","LU0154245756.USD","LU1430594728.SGD","LU2097829019.USD","LU2463526074.USD","LU1066051498.USD","BK4139","BK4134","LU0738911758.USD","LU2237438978.USD","LU2125154778.USD","IE00BZ1G4Q59.USD","LU2125909247.SGD","LU0861579265.USD","BK4532","LU2210150020.SGD","LU1934455863.HKD","BK4566","IE00B3PB1722.GBP","LU1323610961.USD","TBN","MLKN","WOR","BK4161","LU1221951129.SGD","ABVX","LU2506952170.USD","IE00BVYPNW00.USD","LU1934455194.USD","SNX","LU0949170772.SGD","LU0385154629.USD","LU1551013342.USD","IE00B42XCP33.USD","CTAS","LU0345770308.USD","LU0053666078.USD","BK4088","NEOV","LU1934455277.USD","LU2168564495.EUR","PAYX","LU2095319765.USD","LU2210149790.SGD","BK4209","COSW","LU1165135440.EUR","LU0130102774.USD","LU0820561818.USD","LU1066051225.USD","BK4212","BK4547","LU0079474960.USD","IE00BKVL7J92.USD","LU0471298777.SGD","BK4191","LU2506952097.USD","LU1116320901.HKD","BK4106","LU2125154935.USD","LU1496350502.SGD","LU2413666004.HKD","UGE","BK4122","BK4130","LU1543694498.USD","LU2360106947.USD","LU2168564065.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668787739","title":"Aytu Biopharma Inc Expected to Post a Loss of 32 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2668787739","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668787739?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:02","pubTimestamp":1789761749,"startTime":"0","endTime":"0","summary":"Aytu Biopharma Inc <AYTU.OQ> expected to post a loss of32cents a share - Earnings PreviewAytu Biopharma IncAYTU.OQAYTU.Ois expected to  show a fall in quarterly revenue when it reports  results on Sep","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL8N45A1RN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AYTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668942632","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2668942632","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668942632?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:00","pubTimestamp":1789725600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·Thor Indus Inc.                                  4Q       .89   6:30 AM. ·General Mills Inc.                               1Q       .72   7:00 AM. ·TD SYNNEX Corp                                   3Q      4.68   7:00 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEOV","LU0070302665.USD","LU2125910336.SGD","LU2168564222.USD","LU1066051811.HKD","IE0008368304.USD","LU2168563687.JPY","LU1032955483.USD","IE00BVYPNV92.GBP","LU0965509101.SGD","LU0861579265.USD","CTAS","WOR","DRI","BK4088","UGE","LU0310799852.SGD","LU2210149790.SGD","LU0265550946.USD","LU1620156213.USD","LU2506952170.USD","LU2125910179.SGD","LU2125154935.USD","RSPS","BB","DAVA","LU0648001328.SGD","AYTU","LU2168564149.EUR","LU0980610538.SGD","BK4161","LU0130102774.USD","LU0963586101.USD","LU2229751404.USD","MLKN","LU2125909593.SGD","LU1116320901.HKD","BK4533","ABVX","LU2413666004.HKD","LU1221951046.USD","LU0345770308.USD","LU0345770993.USD","BK4130","LU0823434583.USD","BK4547","LU0823434740.USD","IE00BDGV0183.EUR","LU1196500208.SGD","GIS","LU0943347566.SGD","BK4550","LU1506573853.SGD","XLP","LU1496350171.SGD","COTG","BK4006","BK4596","LU0820561909.HKD","BK4143","LU0950375773.USD","BK4139","LU2125909247.SGD","LU1585245621.USD","LU2089279066.USD","RTH","LU2041044095.USD","LU2125154778.USD","LU0949170772.SGD","LU2168564495.EUR","BK4096","LU1620156130.USD","BK4155","COST","BK4104","LU0234572021.USD","LU2097829019.USD","AZO","BK4094","LU0471298777.SGD","LU1934455277.USD","LU2360108059.USD","LU0385154629.USD","LU2237438978.USD","IE00BKVL7J92.USD","LU0823417737.USD","SFIX","SG9999001440.SGD","LU2463526074.USD","CBRL","THO","BK4099","BK4212","LU1721427968.SGD","BK4551","LU1035775433.USD","LU0965509010.AUD","LU1201861249.SGD","LU2433249047.HKD","LU0471298694.HKD","LU0084288595.USD","LU0211327993.USD","PAYX","LU2168564065.EUR","LU2240825500.USD","TRUO","LU1221951129.SGD","LU0234570918.USD","BK4122","IE00BVYPNW00.USD","LU1551013342.USD","LU1543694498.USD","LU1066051498.USD","AQWA","LU0154245756.USD","LU0648005311.SGD","LU2095319765.USD","LU1551013425.SGD","LU2506952097.USD","LU2298321311.HKD","LU1496350502.SGD","FUL","BK4532","LU1037948897.HKD","LU1934455194.USD","LU0265550359.USD","LU2092937221.SGD","IE00B3PB1722.GBP","LU1571399168.USD","LU1323610961.USD","BK4106","BK4097","LU1037948541.HKD","BK4134","LU2506951958.HKD","LU0965509283.SGD","LU1934455863.HKD","LU1116320737.USD","BK4137","LU0661504455.SGD","FSTA","LU0320765489.SGD","IE00B5TLWC47.USD","LU2506951875.HKD","LU1989763690.USD","FERG","LU1430594728.SGD","LU2413665964.HKD","BK4566","LU1165135440.EUR","LU1923621640.USD","LU0738911758.USD","LU2381873111.SGD","LU0053666078.USD","LU0820561818.USD","IE00B42XCP33.USD","IE00BZ1G4Q59.USD","KBH","LU0211328371.USD","LU1923622614.USD","BBUL","TBLU","COSW","LU2210150020.SGD","BK4597","LU2360106947.USD","BK4585","LU2360032135.SGD","BK4191","LU1066051225.USD","IE00BGHQF631.EUR","LU0208291251.USD","LU0417517546.SGD","BK4581","LU1989763427.SGD","BK4007","BK4504","IE00B3T34201.USD","LU0154245673.USD","LU1069344957.HKD","BK4109","LU0314106906.USD","LU1066053197.SGD","LU0238689110.USD","LU1267930490.SGD","LU1596574779.USD","BK4209","BK4214","BK4140","LU0689472784.USD","LU1892829315.USD","XHB","LU0965508806.USD","HK0000819398.USD","SNX","LU0079474960.USD","LU0823417653.USD","LU0256863811.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668860935","title":"Aytu Biopharma Updates Financial Calendar with Fiscal 2026 Results Release and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2668860935","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668860935?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:31","pubTimestamp":1789590662,"startTime":"0","endTime":"0","summary":"Aytu Biopharma updates financial calendar with fiscal 2026 results release and conference callAytu Biopharma will report fiscal 2026 full-year and fourth-quarter results on Sept. 22, 2026.Results call","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDLb0rYS0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AYTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646866623","title":"Aytu Biopharma - Co and Lannett Terminate Metadate Agreement Effective June 23, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2646866623","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646866623?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:37","pubTimestamp":1782419856,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nFWN42X0AP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AYTU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646386664","title":"Aytu Biopharma - to Continue Selling Existing Metadate Inventory and Pay Royalties Until Sales Cease - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2646386664","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646386664?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:37","pubTimestamp":1782419856,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nFWN42X0AP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AYTU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642283217","title":"Aytu BioPharma Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2642283217","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642283217?lang=en_us&edition=fundamental","pubTime":"2026-06-11 18:04","pubTimestamp":1781172240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AYTU/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 11, 2026 06:04 ET (10:04 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYTU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640910964","title":"Aytu BioPharma to present at Planet MicroCap Las Vegas 2026 investor conference fireside Q&A","url":"https://stock-news.laohu8.com/highlight/detail?id=2640910964","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640910964?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:15","pubTimestamp":1780344939,"startTime":"0","endTime":"0","summary":"Aytu BioPharma will join a fireside Q&A at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026.The session is scheduled for 10:30 a.m. Pacific time at the Bellagio Resort & Hotel in Las Vegas.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL1hZ5CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGM","BK4561","LU1571399168.USD","BK4150","BK4588","AYTU","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636300675","title":"Aytu BioPharma to present at Lytham Partners Spring Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2636300675","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636300675?lang=en_us&edition=fundamental","pubTime":"2026-05-19 04:07","pubTimestamp":1779134824,"startTime":"0","endTime":"0","summary":"Aytu BioPharma will present at the Lytham Partners Spring 2026 Investor Conference on May 28, 2026.The virtual webcast is scheduled for 9:15 a.m. ET.Management will also hold virtual one-on-one investor meetings during the event.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL56mNXx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYTU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635748952","title":"Analysts Offer Insights on Healthcare Companies: Assertio Therapeutics (ASRT), Aytu BioScience (AYTU) and Oruka Therapeutics (ORKA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635748952","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635748952?lang=en_us&edition=fundamental","pubTime":"2026-05-14 21:21","pubTimestamp":1778764882,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Assertio Therapeutics (ASRT), Aytu BioScience (AYTU) and Oruka Th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-assertio-therapeutics-asrt-aytu-bioscience-aytu-and-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-assertio-therapeutics-asrt-aytu-bioscience-aytu-and-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0128526141.USD","XBI","LABU","BK4007","BK4585","HCSG","BK4139","AYTU","BK4581","LU0029874061.USD","ORKA","ASRT","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635754888","title":"Aytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635754888","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635754888?lang=en_us&edition=fundamental","pubTime":"2026-05-14 06:39","pubTimestamp":1778711993,"startTime":"0","endTime":"0","summary":"Aytu Biopharma Inc reports results for the quarter ended March 31 - Earnings SummaryAytu Biopharma Inc AYTU.OQ reported a quarterly adjusted loss of 53 cents per share for the quarter ended March 31, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL8N41Q30J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AYTU"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://aytubio.com","stockEarnings":[{"period":"1week","weight":0.0051},{"period":"1month","weight":-0.0922},{"period":"3month","weight":-0.0837},{"period":"6month","weight":-0.2452},{"period":"1year","weight":-0.0922},{"period":"ytd","weight":-0.2423}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.0717},{"period":"1year","weight":0.1241},{"period":"ytd","weight":0.1326}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years of age and above, and Cotempla XR-ODT for patients from six to seventeen years old. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":0.044601},{"month":2,"riseRate":0.2,"avgChangeRate":-0.150336},{"month":3,"riseRate":0.4,"avgChangeRate":0.18333},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.0486},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.102385},{"month":6,"riseRate":0.333333,"avgChangeRate":0.021749},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.016151},{"month":8,"riseRate":0.111111,"avgChangeRate":-0.162026},{"month":9,"riseRate":0.2,"avgChangeRate":-0.051739},{"month":10,"riseRate":0.3,"avgChangeRate":0.183627},{"month":11,"riseRate":0.111111,"avgChangeRate":-0.084654},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.055628}],"exchange":"NASDAQ","name":"Aytu BioScience, Inc.","nameEN":"Aytu BioScience, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aytu BioScience, Inc.(AYTU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Aytu BioScience, Inc.(AYTU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Aytu BioScience, Inc.,AYTU,Aytu BioScience, Inc.股票,Aytu BioScience, Inc.股票老虎,Aytu BioScience, Inc.股票老虎国际,Aytu BioScience, Inc.行情,Aytu BioScience, Inc.股票行情,Aytu BioScience, Inc.股价,Aytu BioScience, Inc.股市,Aytu BioScience, Inc.股票价格,Aytu BioScience, Inc.股票交易,Aytu BioScience, Inc.股票购买,Aytu BioScience, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aytu BioScience, Inc.(AYTU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Aytu BioScience, Inc.(AYTU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction